-transparent.png){kind=logo}
To determine whether non-insulin-dependent diabetes mellitus (NIDDM) is characterized by day-long hypoinsulinemia, we measured 24-h serum profiles for glucose, insulin, and C-peptide by use of a constant-rate blood-withdrawal technique in diabetic and control subjects fed isocaloric meals. When only lean subjects were considered, diabetic subjects (relative body weight 0.99 +/- 0.3) and control subjects (relative body weight 0.95 +/- 0.03) had similar 24-h integrated serum insulin concentrations (13.4 +/- 2.5 vs. 16.1 +/- 2.0 microU/ml, P NS) due to the offsetting effects of increased basal levels and decreased postprandial responses in NIDDM. In contrast, both basal and meal-stimulated insulin levels were decreased in obese NIDDM subjects (relative body weight 1.39 +/- 0.07) compared with obese control subjects (relative body weight 1.60 +/- 0.08), resulting in a 61% reduction in the 24-h integrated insulin value (18.7 +/- 1.5 vs. 48.4 +/- 13.7 microU/ml). Thus, the capacity to increase 24-h integrated serum insulin as a function of relative body weight was impaired in NIDDM subjects (r = 0.27, P NS) compared with control subjects (r = .70, P less than .01). In contrast, 24-h integrated C-peptide was decreased (P less than .01) in both lean (0.92 +/- 0.13 pM/ml) and obese (1.52 +/- 0.19 pM/ml) NIDDM patients compared with the respective control groups (1.50 +/- 0.13 and 3.03 +/- 0.44 pM/ml). The molar ratio of 24-h integrated C-peptide to insulin was diminished in lean but not obese NIDDM compared with control subjects. A 3-wk period of intensive insulin therapy led to normalization of the mean 24-h integrated insulin (but not integrated serum C-peptide) value in NIDDM compared with a control group that had an identical mean relative body weight. The 24-h urinary C-peptide measured on the same day as the serum profile was correlated (P less than .01) with both the 24-h integrated serum insulin (r = .69) and C-peptide (r = .67) concentrations in control subjects but not in NIDDM subjects (r = .20 and .04, respectively, P NS). Additionally, the urinary clearance of C-peptide was increased in NIDDM (38.1 +/- 7.8 vs. 20.4 +/- 1.7 ml/min in control subjects, P less than .05) and varied with treatment status (26.0 +/- 4.6 ml/min after insulin therapy).(ABSTRACT TRUNCATED AT 400 WORDS)
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
August 1981,
Diabetes,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
March 1991,
The Journal of trauma,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
August 1990,
Transplantation proceedings,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
March 1989,
Acta paediatrica Scandinavica,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
September 1989,
Diabetes care,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
December 1997,
Diabetologia,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
July 1990,
Casopis lekaru ceskych,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
October 1991,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
April 1989,
Nihon Ika Daigaku zasshi,
W T Garvey, and
J M Olefsky, and
A H Rubenstein, and
O G Kolterman
July 1986,
The Korean journal of internal medicine,
